Cargando…
Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry
Background: Spinal muscular atrophy (SMA) is the most common neurodegenerative disorder and the leading genetic cause of infant mortality. Early detection of SMA through newborn screening (NBS) is essential to selecting pre-symptomatic treatment and ensuring optimal outcome, as well as, prompting th...
Autores principales: | Lin, Yiming, Lin, Chien-Hsing, Yin, Xiaoshan, Zhu, Lin, Yang, Jianbin, Shen, Yuyan, Yang, Chiju, Chen, Xigui, Hu, Haili, Ma, Qingqing, Shi, Xueqin, Shen, Yaping, Hu, Zhenzhen, Huang, Chenggang, Huang, Xinwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928056/ https://www.ncbi.nlm.nih.gov/pubmed/31921298 http://dx.doi.org/10.3389/fgene.2019.01255 |
Ejemplares similares
-
C4OH is a potential newborn screening marker—a multicenter retrospective study of patients with beta-ketothiolase deficiency in China
por: Lin, Yiming, et al.
Publicado: (2021) -
Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China
por: Zhou, Duo, et al.
Publicado: (2022) -
Spinal Muscular Atrophy Diagnosed by Newborn Screening
por: Lopez-Chacon, Matias, et al.
Publicado: (2019) -
Interventions for spinal muscular atrophy: an impetus for newborn screening
Publicado: (2021) -
Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
por: Jędrzejowska, Maria
Publicado: (2020)